Jupiter Orphan Therapeutics
Jupiter
About Jupiter Orphan Therapeutics
Jupiter Orphan Therapeutics, Inc. (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal office located in Jupiter, FL, USA, was founded in the summer of 2015. In its short period of operations, JOT has assembled a very strong management and scientific team as well as defined three pipeline products which of one is already in Phase II.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Website: jupiterorphan.com
- Phone: +115613087780
Industries & Categories
Genetics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/jupiter-orphan-therapeutics-167179 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.